As chemotherapeutic treatment of patients with hematopoietic malignancies was emerging during the second half of the 20th century it became important to develop measurements and milestones of treatment efficacy. For decades the milestone of “remission” has included microscopic examination of … Continue reading →

Yesterday, Science Daily announced a cool new device that can extract human DNA with full genetic data in minutes. The device is box shaped and handheld, and can extract DNA from fluid samples. Now, extracting DNA can be as easy … Continue reading →

Because pancreatic cancer is often diagnosed after it has spread to other organs, treatment through chemotherapy, surgery, and radiotherapy are generally ineffective. Five-year survival is estimated at less than 5%, with no significant improvements in therapy in recent decades. In a mouse model … Continue reading →

  Last week, the Cancer Immunotherapy Consortium (CIC) held its annual meeting in Washington, DC, entitled “Entering the Era of Combination Therapies: Practical Implementation.”  The meeting was focused on the complexity of developing combination cancer immunotherapies in light of the … Continue reading →

One of the recurrent questions that we field is whether our assay is limited to genomic DNA (gDNA), or can also be applied to cDNA.  The answer is a little bit complicated, so please bear with me.  First, to be … Continue reading →

At the recent annual meeting of the American Association of Cancer Research (AACR) much attention was paid to new immunotherapeutic approaches to cancer based on harnessing a patient’s immune response to recognize and eliminate malignant cells. The immune system is … Continue reading →